Literature DB >> 8006576

Cancer antigens: immune recognition of self and altered self.

A N Houghton1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8006576      PMCID： PMC2191545          DOI： 10.1084/jem.180.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  21 in total

1.  Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

Authors:  D L Barnd; M S Lan; R S Metzgar; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

3.  Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; L Rivoltini; S L Topalian; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

4.  The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.

Authors:  B Schlichtholz; Y Legros; D Gillet; C Gaillard; M Marty; D Lane; F Calvo; T Soussi
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

5.  Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.

Authors:  T Boon; A Van Pel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

6.  Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.

Authors:  C Sibille; P Chomez; C Wildmann; A Van Pel; E De Plaen; J L Maryanski; V de Bergeyck; T Boon
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

7.  The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.

Authors:  S Vijayasaradhi; B Bouchard; A N Houghton
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

8.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.

Authors:  A N Houghton; M Eisinger; A P Albino; J G Cairncross; L J Old
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

9.  Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.

Authors:  F X Real; M J Mattes; A N Houghton; H F Oettgen; K O Lloyd; L J Old
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

10.  The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Authors:  V Brichard; A Van Pel; T Wölfel; C Wölfel; E De Plaen; B Lethé; P Coulie; T Boon
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307
View more
  90 in total

Review 1.  Dendritic cells: a link between innate and adaptive immunity.

Authors:  K Palucka; J Banchereau
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

2.  Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules.

Authors:  G Zeng; C E Touloukian; X Wang; N P Restifo; S A Rosenberg; R F Wang
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis.

Authors:  Hiroto Kita; Shuji Matsumura; Xiao-Song He; Aftab A Ansari; Zhe-Xiong Lian; Judy Van de Water; Ross L Coppel; Marshall M Kaplan; M Eric Gershwin
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 4.  Immune recognition of self in immunity against cancer.

Authors:  Alan N Houghton; José A Guevara-Patiño
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 5.  The next wave of recombinant and synthetic anticancer vaccines.

Authors:  K R Irvine; N P Restifo
Journal:  Semin Cancer Biol       Date:  1995-12       Impact factor: 15.707

6.  Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy.

Authors:  Jonathan P Butchar; Payal Mehta; Steven E Justiniano; Kristan D Guenterberg; Sri-Vidya Kondadasula; Xiaokui Mo; Mahesh Chemudupati; Thirumala-Devi Kanneganti; Amal Amer; Natarajan Muthusamy; David Jarjoura; Clay B Marsh; William E Carson; John C Byrd; Susheela Tridandapani
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

7.  T cell homeostatic proliferation elicits effective antitumor autoimmunity.

Authors:  Wolfgang Dummer; Andreas G Niethammer; Roberto Baccala; Brian R Lawson; Norbert Wagner; Ralph A Reisfeld; Argyrios N Theofilopoulos
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 8.  Biotherapy of cancer. Perspectives of immunotherapy and gene therapy.

Authors:  V Schirrmacher
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells.

Authors:  J M Corman; E E Sercarz; N K Nanda
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 melanoma patients.

Authors:  S Yamasaki; T Okino; N G Chakraborty; W O Adkisson; A Sampieri; S J Padula; F Mauri; B Mukherji
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.